Your browser doesn't support javascript.
loading
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke, Josefine; Ishaque, Naveed; Koll, Randi; Gu, Zuguang; Schumann, Elisa; Sieverling, Lina; Uhrig, Sebastian; Hübschmann, Daniel; Toprak, Umut H; López, Cristina; Hostench, Xavier Pastor; Borgoni, Simone; Juraeva, Dilafruz; Pritsch, Fabienne; Paramasivam, Nagarajan; Balasubramanian, Gnana Prakash; Schlesner, Matthias; Sahay, Shashwat; Weniger, Marc; Pehl, Debora; Radbruch, Helena; Osterloh, Anja; Korfel, Agnieszka; Misch, Martin; Onken, Julia; Faust, Katharina; Vajkoczy, Peter; Moskopp, Dag; Wang, Yawen; Jödicke, Andreas; Trümper, Lorenz; Anagnostopoulos, Ioannis; Lenze, Dido; Küppers, Ralf; Hummel, Michael; Schmitt, Clemens A; Wiestler, Otmar D; Wolf, Stephan; Unterberg, Andreas; Eils, Roland; Herold-Mende, Christel; Brors, Benedikt; Siebert, Reiner; Wiemann, Stefan; Heppner, Frank L.
Affiliation
  • Radke J; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. josefine.radke@med.uni-greifswald.de.
  • Ishaque N; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Germany. josefine.radke@med.uni-greifswald.de.
  • Koll R; Institute of Pathology, Universitätsmedizin Greifswald, Greifswald, Germany. josefine.radke@med.uni-greifswald.de.
  • Gu Z; Digital Health Center, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany. naveed.ishaque@bih-charite.de.
  • Schumann E; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Sieverling L; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Germany.
  • Uhrig S; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Hübschmann D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Toprak UH; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Germany.
  • López C; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hostench XP; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Borgoni S; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Juraeva D; Computational Oncology, Molecular Diagnostics Program, NCT Heidelberg, Heidelberg, Germany.
  • Pritsch F; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Paramasivam N; Computational Oncology, Molecular Diagnostics Program, NCT Heidelberg, Heidelberg, Germany.
  • Balasubramanian GP; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Schlesner M; Department of Pediatric Oncology, Hematology and Immunology, University Hospital, Heidelberg, Germany.
  • Sahay S; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Weniger M; Division Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pehl D; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany.
  • Radbruch H; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), CIBER de Cáncer, Barcelona, Spain.
  • Osterloh A; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Korfel A; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Misch M; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Onken J; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Faust K; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Germany.
  • Vajkoczy P; Molecular Precision Oncology Program, NCT Heidelberg, Heidelberg, Germany.
  • Moskopp D; Hopp Children's Cancer Center, NCT Heidelberg (KiTZ), Heidelberg, Germany.
  • Wang Y; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jödicke A; Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Trümper L; Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg, Germany.
  • Anagnostopoulos I; Institute of Pathology, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Lenze D; Digital Health Center, Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Küppers R; Institute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Hummel M; German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany.
  • Schmitt CA; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Wiestler OD; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Wolf S; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Unterberg A; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Eils R; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Herold-Mende C; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Brors B; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Siebert R; Department for Neurosurgery, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Wiemann S; Department for Neurosurgery, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Heppner FL; Department for Neurosurgery, Vivantes Klinikum Neukölln, Berlin, Germany.
Nat Commun ; 13(1): 2558, 2022 05 10.
Article in En | MEDLINE | ID: mdl-35538064
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Central Nervous System Neoplasms / Epstein-Barr Virus Infections Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse / Central Nervous System Neoplasms / Epstein-Barr Virus Infections Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Type: Article Affiliation country: Germany